Doximity Stock News

Patient investors who buy this unique healthcare stock now could see market-beating returns.

Doximity announced financial results that make its long-term future look bright.

Doximity announced financial results that make its long-term future look bright.

Doximity Inc - Class A (DOCS) shares closed this week 32.0% higher than it did at the end of last week. The stock is currently up 20.3% year-to-date, up 13.8% over the past 12 months, and up 13.8% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $64.95 and as low as $44.65 this week.Shares closed 47.7% below its 52-week high and 41.2% above its 52-week low.Trading volume this week was 42.5% higher than the 10-day average and 121.5% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -5765.5% The company's stock price performance over the past 12 months beats the peer average by -205.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Goldman Sachs has initiated Teladoc and Doximity with buy ratings as the firm has a positive view on the healthcare technology sector for the long term.

Doximity Inc. (NYSE:DOCS)s traded shares stood at 5.57 million during the last session. At the close of trading, the stocks price was $60.32, to imply a decrease of -2.36% or -$1.46 in intraday trading. The DOCS shares 52-week high remains $107.79, putting it -78.7% down since that peak but still an impressive 33.82% since price After The Stock Rose 31.99% Over The Week, Is Doximity Inc. (NYSE: DOCS) Still A Buy? Read More »

These two fast-growing tech stocks deserve a spot on your next buy list.

Advertisers are flocking to the social-media network for doctors.

Doximity Inc - Class A (DOCS) shares closed today 24.0% higher than it did at the end of yesterday. The stock is currently down 0.6% year-to-date, down 6.0% over the past 12 months, and down 6.0% over the past five years. Today, the Dow Jones Industrial Average rose 0.9%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $50.01 and as low as $44.65 this week.Shares closed 42.7% below its 52-week high and 54.8% above its 52-week low.Trading volume this week was 70.2% higher than the 10-day average and 80.5% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -2355.9% The company's stock price performance over the past 12 months beats the peer average by -48.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Advertisers are flocking to the social-media network for doctors.

Doximity shares are soaring today after its fiscal Q3 2022 results yesterday after the bell beat on the top and bottom lines and it issues strong 2022 guidance.

Within the last quarter, Doximity (NYSE: DOCS ) has observed the following analyst ratings:…

Gainers US Ecology, Inc. (NASDAQ: ECOL ) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash. Tritium DCFC Limited (NASDAQ: DCFC ) gained 65.4% to $15.78. Tritium DCFC shares surged nearly 40% Tuesday after the Australian EV charging company announced its new manufacturing facility will be located in the United States. Tritium CEO Jane Hunter appeared at the White House to make the announcement yesterday. Infobird Co., Ltd (NASDAQ: IFBD ) gained 32.6% to $1.2393. Infobird recently signed a contract with subsidiary of Nippi Japan for digital marketing solutions. Doximity, Inc. (NYSE: DOCS ) shares gained 25.1% to $62.30 after the company reported better-than-expected Q3 results and issued FY22 sales guidance above estimates. Aptevo Therapeutics Inc. (NASDAQ: APVO ) jumped 20.5% to $7.29 after the company announced it has earned a $10 million non-dilutive milestone payment related to 2021 sales of RUXIENCE. Absolute Software Corporation (NASDAQ: ABST ) gained 17.9% to $9.47 after the company reported better-than-expected Q2 sales results and issued FY22 sales guidance.

Doximity DOCS +20%. Aptevo Therapeutics APVO +17%. Varex Imaging (VREX) -11%. BioCardia (BCDA) -8%.

NEW YORK , Feb. 9, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DOCS, SEDG, SHOP, DE, and MGM. Full story available on Benzinga.com